Developing novel therapeutics which target epithelial cell repair and regeneration as a key therapeutic axis for maintaining homeostasis of the microbiome and the immune...

Fluxome produces pure and natural resveratrol with ingredients that give beneficial effects to human health.
The compaby xas acquired by Evolva on November 29, 2012.

Galecto is focused on developing novel drugs for the treatment of fibrosis, inflammation, and other serious human diseases. The company’s products target galectins or...

Santaris Pharma A/S uses its proprietary Locked Nucleic Acid (LNA) platform and tissue-targeting expertise to pioneer next-generation antisense product candidates. Santaris...

Vivostat® is the world’s only system for on-site preparation of autologous Platelet Rich Fibrin (PRF®) and fibrin sealant. It provides a range of safe, versatile and...